Clipping of news on Brazilian Culture, Law and Citizenship
02/04/2013
This article was translated by an automatic translation system, and was therefore not reviewed by people.
For the first time since 2004, before being informed index, distributors already readjust prices up 6.31%
Adjustments can reach 6.31%, the government said Hudson Bridges / O Globo
BRASILIA - For the first time since 2004, the federal government has not published the authorization of the annual adjustment of medicines with controlled prices by the end of March. But even without the backing of the Ministry of Health, the distributors began practicing on Monday even increases to 6, 31% in the prices of medicines. The Health Minister Alexandre Padilha, said that the resolution with the percentage increases will be published later this week in the Official Gazette and the adjustments will not be above inflation.
- According to the formula for calculating the Cemed (Regulation Chamber Drug Market), we will not have above inflation adjustment for any category. And most medications have authorized readjustment below what was the IPCA - Padilha said.
The Ministry of Health reported that laboratories are not allowed to raise prices and that this permission will only come from the publication of the indexes. He noted that if there is any correction should be within the ceiling in force for the increase authorized in March last year.
Jorge Froes, executive director of the Brazilian Association of Pharmaceutical Wholesale (Abafarma), said that the distributors have received the lists of industries with new values, and on Monday even started practicing prices.
Accounts by industry, based on the criteria published by the government, the rise could reach 6.31% - which corresponds to the IPCA inflation for the 12 months ended in February. On average they will be at 4.59%, according to industry.
High drug 100, the second consumer association
In the opinion of Jorge Froes, however, the first resolution of the Board of Adjustment, published on March 12, not only established the criteria for the composition of the increase, but also authorized the adjustment from the last 30th. But the specific resolution to the percentage adjustment, which should be published this week, takes into account not only inflation, but also the productivity gains of companies and the price of inputs used in the production of medicines.
The readjustment of the drugs was confirmed by the president of the Association for the Defence of Consumers and Users of Drugs in Rio de Janeiro, Odari Savoie. According to him, in the survey conducted on Monday with the distributors, the entity found to increase by 6% in the cost price of about 100 drugs. One of the distributors that send medicines to the association, Profarma, said he began to pass on Monday the new prices reported by laboratories.
The group also said Panpharma fulfill the provisions in the first and followed the resolution adopted by the pharmaceutical industry adjustment. "Starting today (Monday), the medicine increased 6.31%. The Board of Market Regulation of Medicines, government agency comprised of representatives from various ministries authorized the increase across the country, "the group said, adding that consumers will feel the impact in about 15 days.
According to Eduardo Velho, chief economist at Global Partners INVX, the readjustment of the medicine will bring an impact of 0.17 percentage points in inflation in 2013. But he estimates that this impact will be more than offset by the relief of the basket, which should mean a reduction of 0.40 percentage point in the IPCA. He projects that inflation will end the year at 5.62%.
* Collaborated Clarice Spitz
Read more about this topic in
© 1996 - 2013. All rights reserved Infoglobo Comunicação e Participações SA This material may not be published, broadcast, rewritten or redistributed without permission.
Source: The Globe - Online
Our news are removed entirely from the sites of our partners. For this reason, we can not change their content even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.